The Potential for Deep Learning Technology in Clinical Trials
Journal of Clinical Studies
Deep Learning Quantitative Computed Tomography Analysis in the Australian Idiopathic Pulmonary Fibrosis Registry
ATS Journals
Deep Learning-based Disease Severity Biomarkers on CT; Posthoc Analysis in a Phase 2a Placebo-controlled Study of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis
ATS Journals
Monte Carlo External Control Arm Generation Utilising Real-world Patient Data and Deep Learning-based Quantitative CT Metrics Demonstrates Treatment Effect in the Atlas IPF Trial
ATS Journals
Deep Learning-Based Short-Term Disease Progression Evaluation Supersedes Automated Baseline CT Phenotype in Predicting Outcomes in Idiopathic Pulmonary Fibrosis
ATS Journals
Deep Learning-Based Quantitative CT and CT Phenotype Classification Independently Predict Mortality in Idiopathic Pulmonary Fibrosis, a Prospective Observational Cohort Study
ATS Journals
Deep Learning-based Quantitative CT and Proteomics for Predicting Outcomes in Idiopathic Pulmonary Fibrosis
ATS Journals
Dose-Dependent Change of Inhaled Pirfenidone Seen in Lung Volume and Fibrosis Quantification in Patients With IPF: A Deep Learning Image-Based Analysis of Data From the ATLAS Phase 1b Trial
ATS Journals
Rein Therapeutics and Qureight broaden life science collaboration
Business Weekly
How is deep learning imaging advancing drug discovery for fibrosis?
Drug Discovery World
The role of NHS Big Data and AI technology in unlocking the future of lung and heart disease treatment
pharmaphorum
Qureight and Remedy Cell to validate RC-0315 in Phase Ib trial for IPF
Clinical Trials Arena
Vicore Pharma to track lung fibrosis trial with Qureight's AI-powered imaging platform
FirstWord PHARMA
Qureight tech deployed in lung fibrosis clinical trial
Health Tech World
Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis
Pharma Focus Europe
Qureight and Avalyn launch strategic partnership in pulmonary fibrosis
PharmaTimes Online
Unravelling the most complex disease challenges in history: How AI startups are changing drug discovery
Startups Magazine
Deep Learning–based Segmentation of Computed Tomography Scans Predicts Disease Progression and Mortality in Idiopathic Pulmonary Fibrosis
ATS Journals